Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2026-01-18 @ 4:24 AM
Study NCT ID:
NCT00204659
Status:
COMPLETED
Last Update Posted:
2008-10-20
First Post:
2005-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Sponsor:
University Hospital Tuebingen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
64-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Wolfram Brugger, M.D.
Old Organization:
Schwarzwald-Baar Clinic, Academic Teaching Hospital, Univ. Freiburg
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |